These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 3274544)
1. Current results with triple therapy for heart transplantation. Bolman RM; Olivari MT; Saffitz J; Sibley R; Spadaro J; Cance C; Elick B Transplant Proc; 1987 Feb; 19(1 Pt 3):2490-1. PubMed ID: 3274544 [No Abstract] [Full Text] [Related]
2. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone. MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557 [No Abstract] [Full Text] [Related]
3. Renal consequences of a low dose cyclosporine triple therapy regimen in cardiac transplantation. Bennett WM; Hosenpud J; Pantley G; Cobanoglu A; Starr A; Norman DJ Transplant Proc; 1989 Feb; 21(1 Pt 3):2479-80. PubMed ID: 2650308 [No Abstract] [Full Text] [Related]
4. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation. Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826 [No Abstract] [Full Text] [Related]
5. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation. Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502 [No Abstract] [Full Text] [Related]
6. Successful cadaveric renal transplantation in infants and young children. Ettenger RB; Rosenthal JT; Marik J; Salusky IB; Kamil E; Malekzadeh MH; Fine RN Transplant Proc; 1989 Feb; 21(1 Pt 2):1707-8. PubMed ID: 2652559 [No Abstract] [Full Text] [Related]
7. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation? Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519 [No Abstract] [Full Text] [Related]
8. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months. Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681 [No Abstract] [Full Text] [Related]
9. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients. Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530 [No Abstract] [Full Text] [Related]
10. Elective cyclosporine conversion from triple therapy. Chapman JR; Allen RD; Ekberg H; Lawrence S; Stewart JH Transplant Proc; 1989 Feb; 21(1 Pt 2):1631-2. PubMed ID: 2652532 [No Abstract] [Full Text] [Related]
11. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation. Abbud-Filho M; Barberato JB; Ramalho HJ; Saldanha LB; Casassanta DM; Denadai ER; Zerati S; Bezas AG Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535 [No Abstract] [Full Text] [Related]
12. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation? Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503 [No Abstract] [Full Text] [Related]
14. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone. Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665 [No Abstract] [Full Text] [Related]
15. Triple therapy including cyclosporine A versus conventional regimen--a randomized prospective study in pediatric kidney transplantation. Broyer M; Gagnadoux MF; Guest G; Niaudet P Transplant Proc; 1987 Oct; 19(5):3582-5. PubMed ID: 3313862 [No Abstract] [Full Text] [Related]
16. Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients. Perkins JD; Sterioff S; Wiesner RH; Offord KP; Rakela J; Dickson ER; Krom RA Transplant Proc; 1987 Feb; 19(1 Pt 3):2434-6. PubMed ID: 3274533 [No Abstract] [Full Text] [Related]
17. Treatment of chronic renal allograft rejection with cyclosporine and prednisone. Rosenblum ND; Harmon WE; Levey RH Transplantation; 1988 Jan; 45(1):232-4. PubMed ID: 3276052 [No Abstract] [Full Text] [Related]
18. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive? Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657 [No Abstract] [Full Text] [Related]
19. Cyclosporin A as sole immunosuppressive agent for renal transplantation in children: effect on catch-up growth. Hodson EM; Knight JF; Sheil AG; Roy LP Transplant Proc; 1989 Feb; 21(1 Pt 2):1687-92. PubMed ID: 2652553 [No Abstract] [Full Text] [Related]
20. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone. Schweizer RT; Rovelli M; Roper L; Bartus SA Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062 [No Abstract] [Full Text] [Related] [Next] [New Search]